These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6483302)

  • 1. Characterization and survival of patients with serous cystadenocarcinoma of the ovaries.
    Demopoulos RI; Bigelow B; Blaustein A; Chait J; Gutman E; Dubin N
    Obstet Gynecol; 1984 Oct; 64(4):557-63. PubMed ID: 6483302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the dissemination process in patients with serous cystadenocarcinoma of the ovaries].
    Dzhilavian GA
    Vopr Onkol; 1984; 30(8):83-6. PubMed ID: 6485289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Superficial lymph node metastasis from ovarian cancer--an analysis of 31 cases].
    Hou YJ
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):466-8. PubMed ID: 2076648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the prognostic factors in patients with stage-I and -II ovarian cancer treated by an operation + irradiation variant].
    Tarlowska L; Czesnin K; Psikuta M; Romejko M
    Vopr Onkol; 1986; 32(3):36-44. PubMed ID: 3962255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and survival rate of patients with serous cystadenocarcinoma of the ovaries.
    Netchajeva ID; Kotova DG
    Neoplasma; 1976; 23(4):439-43. PubMed ID: 1004656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.
    Gershenson DM; Sun CC; Lu KH; Coleman RL; Sood AK; Malpica A; Deavers MT; Silva EG; Bodurka DC
    Obstet Gynecol; 2006 Aug; 108(2):361-8. PubMed ID: 16880307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival of patients with malignant tumors of the ovaries in relation to the stage according to the TNM classification].
    Kotova DG
    Vopr Onkol; 1976; 22(1):36-43. PubMed ID: 1266119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
    Liu JF; Hirsch MS; Lee H; Matulonis UA
    Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-morphological characteristics and results of treatment of endometrioid cystadenocarcinoma of the ovary].
    Vinokurov VL; Livshits MA; Tsyrlina EV; Kolosov AE
    Vopr Onkol; 1983; 29(12):49-56. PubMed ID: 6420990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
    Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS
    Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma.
    Killackey MA; Davis AR
    Gynecol Oncol; 1993 Nov; 51(2):171-4. PubMed ID: 8276289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of solid ovarian tumors in Tokai District (author's transl)].
    Tomoda Y; Ohta M; Ushijuma H; Nakashima N; Chihara T; Nishi H; Tokuhashi Y; Inagaki K; Umemura S; Manabe O; Saiki N; Iida S; Okamoto M; Hori M; Arii Y; Kazeto S; Asai Y; Kobayashi I; Murase Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Nov; 33(11):1881-7. PubMed ID: 7320591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.